Compounds > 1,7-dimethylxanthine
Page last updated: 2024-11-02

1,7-dimethylxanthine and Substance Withdrawal Syndrome

1,7-dimethylxanthine has been researched along with Substance Withdrawal Syndrome in 2 studies

1,7-dimethylxanthine : A dimethylxanthine having the two methyl groups located at positions 1 and 7. It is a metabolite of caffeine and theobromine in animals.

Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Van Soeren, MH1
Sathasivam, P1
Spriet, LL1
Graham, TE1
Biaggioni, I1
Paul, S1
Puckett, A1
Arzubiaga, C1

Trials

1 trial available for 1,7-dimethylxanthine and Substance Withdrawal Syndrome

ArticleYear
Caffeine metabolism and epinephrine responses during exercise in users and nonusers.
    Journal of applied physiology (Bethesda, Md. : 1985), 1993, Volume: 75, Issue:2

    Topics: Adult; Blood Glucose; Caffeine; Catecholamines; Epinephrine; Exercise; Fatty Acids, Nonesterified; G

1993

Other Studies

1 other study available for 1,7-dimethylxanthine and Substance Withdrawal Syndrome

ArticleYear
Caffeine and theophylline as adenosine receptor antagonists in humans.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 258, Issue:2

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adult; Caffeine; Heart Rate; Humans; Male; Platelet Ag

1991